Stheno
Atlanta
About Stheno
Stheno Corporation develops chiral analysis instruments to check chiral purity in agrochemicals, flavors and fragrance ingredients, and pharmaceuticals. Its product 1000-OR, which is based on magneto-optical enantiomeric detection technology is used in various applications such as achiral stationary phase HPLC separations monitoring for optical activity, chiral stationary phase HPLC separations monitoring for chiral signature, gradient method HPLC separation monitoring, online process monitoring, HPLC/MS chiral signature determination, and species identification for analyses lacking accessible chromophore. Stheno Corporation is a U.S.-based company that was founded in 2003. The company was acquired by Spectra Analysis Instruments on November 1, 2008.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.5M
- Funding stage: M&A
- Last round: Debt Financing (Apr 2007)
- Website: sthenocorp.com
- Phone: +1 404-526-6193
Industries & Categories
Analytics, Electronics
Canonical: https://fsome.com/organization/stheno-2123664 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.